ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 118 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $61,571 | -35.2% | 13,385 | -9.0% | 0.04% | -33.9% |
Q2 2023 | $95,052 | +26.3% | 14,714 | +47.4% | 0.06% | +36.6% |
Q1 2023 | $75,272 | -46.3% | 9,983 | -27.8% | 0.04% | -43.8% |
Q4 2022 | $140,068 | +19.7% | 13,827 | +16.4% | 0.07% | +55.3% |
Q3 2022 | $117,000 | -6.4% | 11,876 | +0.8% | 0.05% | +2.2% |
Q2 2022 | $125,000 | +8.7% | 11,784 | 0.0% | 0.05% | -9.8% |
Q1 2022 | $115,000 | -35.4% | 11,784 | -5.6% | 0.05% | -23.9% |
Q4 2021 | $178,000 | +2.3% | 12,482 | +44.1% | 0.07% | -13.0% |
Q3 2021 | $174,000 | -13.0% | 8,664 | -4.9% | 0.08% | -6.1% |
Q2 2021 | $200,000 | – | 9,111 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |